Literature DB >> 36042115

Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.

Maryam Farzaneh1, Sajad Najafi2, Mahrokh Abouali Gale Dari3, Mohadeseh Sheykhi-Sabzehpoush4, Diyan Dayer1, Maryam Cheraghzadeh5, Shirin Azizidoost6.   

Abstract

Gynecologic cancers are reproductive disorders characterized by pelvic pain and infertility. The identification of new predictive markers and therapeutic targets for the treatment of gynecologic cancers is urgently necessary. One of the recent successes in gynecologic cancers research is identifying the role of signaling pathways in the pathogenesis of the disease. Recent experiments showed long noncoding RNAs (lncRNA) can be novel therapeutic approaches for the diagnosis and treatment of gynecologic cancers. LncRNA are transcribed RNA molecules that play pivotal roles in multiple biological processes by regulating the different steps of gene expression. Metastasis-associated lung adenocarcinoma transcript-1 (MALAT1) is a well-known lncRNA that plays functional roles in gene expression, RNA processing, and epigenetic regulation. High expression of MALAT1 is closely related to numerous human diseases. It is generally believed that MALAT1 expression is associated with cancer cell growth, autophagy, invasion, and metastasis. MALAT1 by targeting multiple signaling pathways and microRNAs (miRNAs) could contribute to the pathogenesis of gynecologic cancers. In this review, we will summarize functional roles of MALAT1 in the most common gynecologic cancers, including endometrium, breast, ovary, and cervix.
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  Gynecologic cancers; Long non-coding RNAs; MALAT1; Signaling pathways; miRNAs

Year:  2022        PMID: 36042115     DOI: 10.1007/s12094-022-02914-8

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.340


  104 in total

1.  Ribosome profiling reveals resemblance between long non-coding RNAs and 5' leaders of coding RNAs.

Authors:  Guo-Liang Chew; Andrea Pauli; John L Rinn; Aviv Regev; Alexander F Schier; Eivind Valen
Journal:  Development       Date:  2013-05-22       Impact factor: 6.868

Review 2.  The long noncoding RNA Malat1: Its physiological and pathophysiological functions.

Authors:  Xuejing Zhang; Milton H Hamblin; Ke-Jie Yin
Journal:  RNA Biol       Date:  2017-10-06       Impact factor: 4.652

3.  Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation.

Authors:  Robert B Gilchrist; Lesley J Ritter; Samu Myllymaa; Noora Kaivo-Oja; Rebecca A Dragovic; Theresa E Hickey; Olli Ritvos; David G Mottershead
Journal:  J Cell Sci       Date:  2006-08-22       Impact factor: 5.285

Review 4.  The function of LncRNA-ATB in cancer.

Authors:  Amir Anbiyaiee; Mohammad Ramazii; Siamak Soltani Bajestani; Seyed Mohammadmahdi Meybodi; Mona Keivan; Seyed Esmaeil Khoshnam; Maryam Farzaneh
Journal:  Clin Transl Oncol       Date:  2022-05-21       Impact factor: 3.405

Review 5.  The role of LncRNA MCM3AP-AS1 in human cancer.

Authors:  Shirin Azizidoost; Farhoodeh Ghaedrahmati; Mohadeseh Sheykhi-Sabzehpoush; Shahab Uddin; Mehri Ghafourian; Abdolah Mousavi Salehi; Mona Keivan; Maryam Cheraghzadeh; Zahra Nazeri; Maryam Farzaneh; Seyed Esmaeil Khoshnam
Journal:  Clin Transl Oncol       Date:  2022-08-24       Impact factor: 3.340

6.  Many lncRNAs, 5'UTRs, and pseudogenes are translated and some are likely to express functional proteins.

Authors:  Zhe Ji; Ruisheng Song; Aviv Regev; Kevin Struhl
Journal:  Elife       Date:  2015-12-19       Impact factor: 8.140

7.  Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model.

Authors:  Kai-Ti Lin; Shu-Pin Sun; Jui-I Wu; Lu-Hai Wang
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

8.  GYNOCARE Update: Modern Strategies to Improve Diagnosis and Treatment of Rare Gynecologic Tumors-Current Challenges and Future Directions.

Authors:  Riccardo Di Fiore; Sherif Suleiman; Bridget Ellul; Sharon A O'Toole; Charles Savona-Ventura; Ana Felix; Valerio Napolioni; Neil T Conlon; Ayse Elif Erson-Bensan; Ilker Kahramanoglu; Miriam J Azzopardi; Miriam Dalmas; Neville Calleja; Mark R Brincat; Yves Muscat-Baron; Maja Sabol; Vera Dimitrievska; Angel Yordanov; Mariela Vasileva-Slaveva; Kristelle von Brockdorff; Rachel A Micallef; Paul Kubelac; Patriciu Achimaș-Cadariu; Catalin Vlad; Olga Tzortzatou; Robert Poka; Antonio Giordano; Alex Felice; Nicholas Reed; C Simon Herrington; David Faraggi; Jean Calleja-Agius
Journal:  Cancers (Basel)       Date:  2021-01-27       Impact factor: 6.639

9.  SCUBE3 downregulation modulates hepatocellular carcinoma by inhibiting CCNE1 via TGFβ/PI3K/AKT/GSK3β pathway.

Authors:  Pan Xu; Aoran Luo; Chuan Xiong; Hong Ren; Liang Yan; Qiang Luo
Journal:  Cancer Cell Int       Date:  2022-01-03       Impact factor: 5.722

Review 10.  Gynecological cancers: A summary of published Indian data.

Authors:  Amita Maheshwari; Neha Kumar; Umesh Mahantshetty
Journal:  South Asian J Cancer       Date:  2016 Jul-Sep
View more
  1 in total

Review 1.  The stem cell-specific long non-coding RNAs in leukemia.

Authors:  Maryam Farzaneh; Sajad Najafi; Mohadeseh Sheykhi-Sabzehpoush; Fereshteh Nezhad Dehbashi; Omid Anbiyaee; Ava Nasrolahi; Shirin Azizidoost
Journal:  Clin Transl Oncol       Date:  2022-09-27       Impact factor: 3.340

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.